Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Jinwoo Bio Co. Ltd. is currently managing 3 pending office actions within the Chemistry & Materials technology area. These actions are assigned to 3 distinct examiners across 3 distinct art units, indicating that each active application is being handled by a different individual in a different technical group. This distribution suggests that the company's current filings in the chemistry sector are broad enough to span multiple specialized classifications. CAMIE S THOMPSON is the busiest examiner for the portfolio, currently overseeing 1 pending office action.
Since each of the 3 distinct examiners is responsible for exactly 1 pending action, the workload is evenly spread across the patent office. This requires the company to adapt to the specific styles of different examiners and the varying standards of multiple art units. The lack of concentration in any single art unit or examiner means that the pending office actions are likely independent of each other. Practitioners should be prepared for a diverse prosecution experience, as the data shows no overlap in examiners or art units for the current active matters in the Chemistry & Materials area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| THOMPSON, CAMIE S | 1 | 73.7% | +10.5% |
| PHAN, DOAN THI-THUC | 1 | 42.8% | +47.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18711120 | HYALURONIC ACID FILM WITH EXCELLENT PERCUTANEOUS ABSORPTION AND MANUFACTURING METHOD THEREFOR | PHAN, DOAN THI-THUC | 56d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18711120 | HYALURONIC ACID FILM WITH EXCELLENT PERCUTANEOUS ABSORPTION AND MANUFACTURING METHOD THEREFOR | PHAN, DOAN THI-THUC | 56d |
| 18889424 | HYALURONATE NANOFABRIC SHEET AND MANUFACTURING METHOD THEREFOR | THOMPSON, CAMIE S | — |
| Art Unit | Apps |
|---|---|
| 1786 | 1 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18889424 | HYALURONATE NANOFABRIC SHEET AND MANUFACTURING METHOD THEREFOR | THOMPSON, CAMIE S | 1786 | §103 | Non-Final OA | — | Pending | Sep 19, 2024 |
| 18711120 | HYALURONIC ACID FILM WITH EXCELLENT PERCUTANEOUS ABSORPTION AND MANUFACTURING METHOD THEREFOR | PHAN, DOAN THI-THUC | 1613 | §103§112 | Final Rejection | 56d | Pending | May 17, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialJinwoo Bio Co. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Camie S Thompson has the most, with 1 of Jinwoo Bio Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
